1. Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
   Noa G. Holtzman et al, 2021, Frontiers in Oncology CrossRef
2. Lysophosphatidic acid-1-receptor targeting agents for fibrosis
   Chloé Rancoule et al, 2011, Expert Opinion on Investigational Drugs CrossRef
3. Expression of autotaxin and lysophosphatidic acid receptors 1 and 3 in the developing rat lung and in response to hyperoxia
   G. H. Shim et al, 2015, Free Radical Research CrossRef
4. Aspartate β-hydroxylase as a target for cancer therapy
   Madiha Kanwal et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
5. The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma
   Tian Xue et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
6. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis
   David C Budd et al, 2013, Future Medicinal Chemistry CrossRef
7. Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics
   Zhenhua Zhang et al, 2022, Frontiers in Oncology CrossRef
8. Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase
   Sebastian Wirsching et al, 2022, International Journal of Molecular Sciences CrossRef